Randomised EValuation of Therapies for microvAscuLar Injury in STEACS

NCT06935383 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CorFlow Therapeutics AG